Remdesivir, the only antiviral authorized for COVID-19 in US, does not improve chances of survival, a massive WHO study found

5 years ago 1 min read

Gilead’s antiviral drug remdesivir, taken by US President Donald Trump, doesn’t stop COVID-19 patients dying or shorten hospital stays, the WHO found.

Leave a Reply

Your email address will not be published. Required fields are marked *

More Stories

1 min read

Record Korean Cases; Trader’s Guide to Rollout: Virus Update

5 years ago
1 min read

California Hits Record; Trader’s Guide to Rollout: Virus Update

5 years ago
1 min read

AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push

5 years ago

You may have missed

1 min read

Record Korean Cases; Trader’s Guide to Rollout: Virus Update

5 years ago
1 min read

LGBTQ-inclusive books are hard to find. So these groups started sending them to schools.

5 years ago
1 min read

At least six arrested as ‘Stop the Steal’ protesters and counter-protesters clash in Washington, DC

5 years ago
1 min read

Brazil rolls out COVID-19 vaccination plan

5 years ago